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Molecular cloning studies have demonstrated the existence of five different muscarinic receptors (ml-m5). While ml, m3 and m5 strongly couple 
to stimulation of phosphoinositide (PI) hydrolysis, m2 and m4 are more efficiently linked to inhibition of adenylate cyclase. The sequences of ml-m5 
have a short segment at the N-terminal portion of the putative third cytoplasmic loop (i3) which is highly conserved among ml, m3 and m5, but 
different from the sequence which is well conserved among m2 and m4. To study the role of this region in conferring coupling selectivity, we con- 
structed cDNAs encoding chimer&. m2/m3 receptors. Transient expression of these receptor hybrids in COS-7 cells showed that a 17 amino acid 
segment at the N-terminal portion of i3 is a major determinant of how efficiently the different muscarinic receptors are coupled to PI hydrolysis. 
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1. INTRODUCTION 
Molecular cloning studies have established the exist- 
ence of five molecularly distinct muscarinic receptors 
(ml-m5) [l-4]. Accumulating evidence suggests that 
the individual receptor subtypes have the capacity to 
preferentially activate or inhibit specific cellular signal 
transduction pathways [S-l I]. Expression studies in 
mammalian cells have shown that ml, m3 and m5 are 
efficiently coupled to phosphoinositide (PI) breakdown 
[6,7,10,11] but do not inhibit adenylate cyclase [ll]. In 
contrast, m2 and m4 are not or only poorly linked to PI 
hydrolysis but strongly inhibit adenylate cyclase activity 
Vll. 
of these receptor chimeras to stimulate PI hydrolysis 
was studied in transfected COS-7 cells transiently ex- 
pressing the clonal receptors. 
2. MATERIALS AND METHODS 
2.1. con!itFucts 
A recent electrophysiological study on ml/m2 recep- 
tor chimeras suggests that the putative third 
cytoplasmic loop (i3; fig.2) plays a crucial role in the 
selective coupling of muscarinic receptors to their in- 
tracellular effector systems [ 131. Sequence analysis 
reveals that a 16-17 amino acid segment at the N- 
terminal portion of i3 is highly conserved among ml, 
m3 and m5, but different from the sequence which is 
well conserved in m2 and m4 (fig.1). In order to study 
the potential role of this domain in conferring coupling 
selectivity, we constructed cDNAs encoding chimeric 
m2/m3 receptors in which either this small fragment or 
the whole i3 loop have been exchanged between the 
human m2 and the rat m3 receptor (fig.2). The ability 
Two restriction sites were introduced into the human m2 expression 
clone described in [3] to facilitate the creation of chimeric receptors. 
An Nhe I site homologous to the one in transmembrane r gion VI of 
the rat m3 receptor [3] was introduced by oligonucleotide-directed 
mutagenesis [14] without changing the amino acid sequence. A Hpa 
I site was created at amino acids 225-226 in the i3 region of m2 which 
changed amino acid 226 from Ala to Asn. These sites were used in 
conjunction with a BspH I site found in transmembrane r gion V of 
both m2 (amino acids 201-203) and m3 (amino acids 246-248) and a 
Stu I site at amino acids 268-269 in the i3 segment of m3. To change 
the whole i3 domain (and causing a Be-Val change in transmembrane 
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R=H m4 IMTVLYIHISLASRSRVHKHRPEGPKEKKAKTLAFLK 
R m2 IMTVLYWHISRASKSRIKKEXKEPVANQDPVSPSLVQ 
H m2 IMTVLYWnIsRAsKsRIKKDKKEPVANQDPVSPSLVQ 
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R=H m3 IMTILYW~&3,QASGTEAEAENEVH 
R m5 ~TILYCRIY~TE~T~~~SDS~~P 
H m5 ~TILYCRIY~TE~T~~L~SDS~~~P 
R=H ml ~CTL~IY~T~~~~SETPGKGG~SSS 
Fig.1. Comparison of the primary sequences of ml-m5 (H = human, 
R=rat) at the amino terminus of the third cytoplasmic loop (i3). V 
indicates the C-terminal portion of the putative fifth transmembrane 
spanning segment. Asterisks represent positions at which all 
muscarinic receptors are either identical or only conservative 
substitutions occur. Circles indicate residues which are conserved only 
within the two functional classes of receptors (even vs odd). The 
underlined sequences have been exchanged between the human m2 
and the rat m3 receptor. 
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Fig.2. Structure of m2/m3 receptor chimeras. The putative 
transmembrane s gments are numbered I-VII from the NHrterminus 
(extracellular) to the COOH-terminus (intracellular). The putative 
third cytoplasmic loop is named i3. Portions shown in black represent 
m3 sequences, while open lines indicate m2 sequences. 
region V), the BspH I-Nhe I fragments from the two receptors were 
exchanged. To change the first 16-17 amino acids of the i3 region, 
double-stranded oligodeoxyribonucleotides of the appropriate se- 
quence were prepared with an automatic DNA synthesizer (Applied 
Biosystems) to substitute for the BspH I-Hpa I fragment of m2 or the 
BspH I-Stu I fragment of m3. The identity of the constructs was con- 
firmed by sequencing 1151 the regions derived from the synthetic oli- 
godeoxyribonucleotides and by restriction endonuclease analysis. 
2.2. Transfections and binding assays 
COS-7 cells (- 70% confluent) were transfected in 10 cm plates 
with 20 pg plasmid DNA by calcium phosphate precipitation [161. The 
plasmid DNAs used for transfections consisted of the muscarinic on- 
structs inserted into the Okayama/Berg pCDI expression vector 1171 
carrying the SV 40 promoter. Media (DMEM) were changed 24 h after 
transfection, and cell membranes were obtained 48 h later as de- 
scribed previously [18]. Binding buffer consisted of 25 mM sodium 
phosphate (pH 7.4) containing 5 mM MgCl2. For direct binding 
assays, 6-8 different concentrations (0.025-3.2 nM) of N- 
[3H]methylscopolamine ([3H]NMS; 85 Ci/mmol, NEN) were used. In 
the carbachol displacement experiments, 10 different carbachol con- 
centrations (0.05-1000 PM) were employed. The [‘H]NMS concentra- 
tion used in these experiments was 0.8 nM (m2, m2/m3-i3, 
m2/m3-17aa) or 0.2 nM (m3), respectively. Nonspecific binding was 
defined by 1 PM atropine. Incubations were carried out at room 
temperature for 2 h. Binding data were analyzed by a nonlinear least- 
squares curve-fitting procedure as detailed in 1181 using the program 
DATAPLOT run on a VAX II computer. 
Protein concentrations were determined according to the method of 
Bradford [19] using a Bio-Rad protein assay kit. 
2.3. PI assay 
COS-7 cells were incubated in 10 cm plates with 3 &i/ml [‘H]myo- 
inositol (ARC; 23 Ci/mmol) for 48 h starting 24 h after transfection. 
The cells were then washed twice with phosphate-buffered saline 
(PBS) and lifted from the dish bottoms with 2 ml of divalent cation- 
free DMEM containing 1 mM EDTA. After centrifugation, cells were 
resuspended in 18 ml of DMEM containing 25 mM Hepes and 10 mM 
LiCl and incubated at room temperature for 10 min. Aliquots (1 ml) 
of the cell suspension were then put into 13 x 100 mm glass tubes. 
After addition of various concentrations of carbachol (O.l-1000 pM), 
cells were incubated for 1 h at 37°C. Cells were then collected by cen- 
trifugation and incubated on ice with 1 ml of 10% trichloroacetic acid 
(TCA) for 30 min. The TCA was extracted with diethylether (4 x 4 ml) 
and levels of IP, were determined using anion exchange 
chromatography [20] and a LKB liquid scintillation counter. 
3. RESULTS 
3.1. Binding studies 
While [3H]NMS showed no detectable binding to 
non-transfected COS-7 cells, specific [3H]NMS binding 
could be demonstrated after transfection with the 
various chimeric receptor genes. m2/m3-i3 and 
m2/m3-17aa bound [3H]NMS with affinities similar to 
that of m2 (KD- 0.8 nM), whereas m3, m3/m2-i3 and 
m3/m2-16aa displayed an about 3-5 fold higher affini- 
ty (KD-0.2 nM) (table 1). 
The B,, values obtained for m3/m2-i3 and 
m3/m2-16aa were considerably lower than those deter- 
mined for the other receptors (table 1). Thus, the 
relative inability of these two receptor chimeras to effi- 
Table 1 
Functional expression of chimeric m2/m3 receptors in COS-7 cells 
PI assay 
Maximum increase EGO wM) 
in 1P1 levels (O70) 
[3H]NMS binding 
Kn[3H]NMS (nM) B,,, (fmol/mg 
protein) 
Carhachol binding 
ICso GM) “H (Hill 
coefficient) 
m2 
m2/m3-i3 
m2/m3-17aa 
m3 
m3/m2-i3 
m3/m2-16aa 
41* 6 
233 f 43 
137*23 
141+ 24 
38*12 
24+ 6 
17.0 +7.5 
0.55kO.18 
5.1 kO.6 
0.29+0.11 
* 
* 
0.79+0.11 
0.79kO.13 
0.80+0.21 
0.17*0.03 
0.25kO.13 
0.25kO.14 
1549i 118 
2651+114 
1643+324 
739* 114 
135* 60 
171* 91 
6.1kl.2 
45.9iZ7.9 
4.lk2.2 
41.8i4.2 
n.d. 
n.d. 
0.89kO.11 
0.67 + 0.09 
0.75 f 0.03 
0.71 Zto.05 
n.d. 
n.d. 
The values represent means of 2-4 independent experiments each performed in duplicate. In case of [‘H]NMS binding, Hill coefficients 
were not significantly different from unity; n.d., not determined 
*not determinable with sufficient accuracy 
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Fig.3. Carbachol-induced increases in IPI levels in transfected COS-7 
cells transiently epressing m2, m3 and m2/m3 receptor hybrids. The 
values represent means of 3-4 independent experiments each 
performed in duplicate. Typical standard errors are shown for a 
carbachol concentration of 100 FM. 
ciently stimulate PI hydrolysis (see below) cannot be 
ascribed with certainty to their primary structures. 
Carbachol displacement experiments were performed 
with those receptors which were expressed at high levels 
in COS-7 cells (m2, m3, m2/m3-i3 and m2/m3-17aa). 
Carbachol inhibited [3H]NMS binding to m2/m3-17aa 
with a potency similar to that of m2, while m2/m3-i3 
gave an about &fold greater I& value (table 1). 
3.2. PI assay 
The ability of the chimeric receptors to stimulated PI 
hydrolysis was determined by studying carbachol- 
induced increases in inositol monophosphate (IPr) 
levels in transiently transfected COS-7 cells. In non- 
transfected cells, carbachol treatment had no detectable 
effect on IPi levels. As shown in fig.3, carbachol 
stimulation resulted in dose-dependent increases in IPr 
levels in native m2 and m3 as well as in all hybrid recep- 
tors studied. These effects could be completely blocked 
by 10 PM of atropine. 
Large quantitative differences in the ability of the in- 
dividual receptors to stimulate PI hydrolysis were 
observed. The maximum increases in IPr levels were 
3-10 times higher for m3, m2/m3-i3 and m2/m3-17aa 
than for m2, m3/m2-i3 and m3/m2-16aa (fig.3, table 
1). The carbochol EC50 values were considerably lower 
for m3 and m2/m3-i3 than for the other receptors 
(fig.3, table 1). While m2/m3-i3 gave a carbachol EC50 
value comparable to that of m3, this value was about 
lo-20 fold higher for m2/m3-17aa (table 1). 
4. DISCUSSION 
In this study cDNAs encoding chimeric m2/m3 
receptors were constructed and transiently expressed in 
COS-7 cells in order to identify intracellular domains 
responsible for the selective coupling of the m3 receptor 
to PI hydrolysis [7,10,11]. 
In accordance with previous binding studies [18], 
[3H]NMS showed a 4-5 fold higher affinity to m3 than 
to m2. This difference in binding affinities remained 
essentially unaltered when the i3 region or parts of it 
were exchanged between m2 and m3 (table 2). This 
finding corroborates the view that the i3 domain is not 
involved in the selective binding of muscarinic antago- 
nists 1131. 
As previously described [7,10,11,12], we observed 
that m3 mediates a strong stimulation of PI metabolism 
while m2 is only poorly linked to this effector system 
(fig.3, table 1). Replacement of the i3 domain of m2 by 
the corresponding m3 sequence led to a receptor 
chimera (m2/m3-i3) which, similar to m3, induced a 
strong PI response with an EDSO also comparable to 
that of m3 (fig.3, table 1). The fact that the maximum 
response generated by m2/m3-i3 was even higher than 
that of native m3 may be due to its very high levels of 
expression (table 1). This finding indicates that the i3 
segment of the muscarinic receptors plays a pivotal role 
in determining how efficiently the different muscarinic 
receptors are linked to PI hydrolysis. 
Our data are consistent with a recent study on ml /m2 
receptor chimeras expressed in Xenopus oocytes show- 
ing that the i3 segment is responsible for the selective 
coupling of ml and m2 to different electrophysiological 
responses [ 131. Since it has been shown that inositol 
1,4,5triphosphate (IP3), a major product of PI 
hydrolysis, mimics the current responses induced by ml 
and m3 [21], it becomes clear that the i3 domain of 
these receptors specifies both the biochemical and the 
electrophysiological responses. Altogether, these data, 
in conjunction with a recent biochemical investigation 
of cu2/p2 receptor hybrids [22], suggest hat the i3 do- 
main may generally determine the coupling selectivity 
of G protein-linked receptors. 
Our result also indicate that a short stretch of 16-17 
amino acids at the N-terminal portion of the i3 loop is 
a major determinant of how efficiently the individual 
muscarinic receptors are coupled to PI breakdown. In- 
troduction of this small segment from m3 into m2 yield- 
ed a receptor hybrid (m2/m3-17aa) which mediated a 
pronounced increase in IPr levels comparable in mag- 
nitude to that of m3 (table 1). However, m2/m3-17aa 
displayed an about 20-fold higher EC50 for carbachol 
than m3 in inducing this response (table 1). Since the 
binding data (table 1) suggest that this reduction in 
potency is not due to a decrease in carbachol affinity, it 
appears that other yet unidentified domains of the i3 
loop (most likely the C-terminal portion) are involved 
in conferring full coupling efficiency. This view is in 
agreement with the finding that deletion mutants of the 
02 receptor which lacked short amino or carboxy ter- 
minal sequences of the i3 domain were no longer able to 
mediate a stimulation of adenylate cyclase [23]. 
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To provide a more thorough examination of the 
mechanisms controlling second messenger selectivity of 
the different muscarinic receptors, we are presently 
establishing cell lines stably expressing the chimeric 
receptors described here as well as creating chimeras in- 
volving the 20 amino acids at the C-terminus of i3. The 
stable cell lines should allow us to better control recep- 
tor numbers and to determine if there are reciprocal ef- 
fects in coupling to inhibition of adenylate cyclase. 
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